111 related articles for article (PubMed ID: 16139243)
1. Hepatitis C virus proteins exhibit conflicting effects on the interferon system in human hepatocyte cells.
Dansako H; Naka K; Ikeda M; Kato N
Biochem Biophys Res Commun; 2005 Oct; 336(2):458-68. PubMed ID: 16139243
[TBL] [Abstract][Full Text] [Related]
2. Activation of the interferon-inducible 2'-5'-oligoadenylate synthetase gene by hepatitis C virus core protein.
Naganuma A; Nozaki A; Tanaka T; Sugiyama K; Takagi H; Mori M; Shimotohno K; Kato N
J Virol; 2000 Sep; 74(18):8744-50. PubMed ID: 10954577
[TBL] [Abstract][Full Text] [Related]
3. The hepatitis C virus core protein can modulate RNA-dependent RNA synthesis by the 2a polymerase.
Wen Y; Cheng Kao C
Virus Res; 2014 Aug; 189():165-76. PubMed ID: 24874198
[TBL] [Abstract][Full Text] [Related]
4. Limited suppression of the interferon-beta production by hepatitis C virus serine protease in cultured human hepatocytes.
Dansako H; Ikeda M; Kato N
FEBS J; 2007 Aug; 274(16):4161-76. PubMed ID: 17651439
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis C virus NS5B delays cell cycle progression by inducing interferon-beta via Toll-like receptor 3 signaling pathway without replicating viral genomes.
Naka K; Dansako H; Kobayashi N; Ikeda M; Kato N
Virology; 2006 Mar; 346(2):348-62. PubMed ID: 16325882
[TBL] [Abstract][Full Text] [Related]
6. Differential activation of interferon-inducible genes by hepatitis C virus core protein mediated by the interferon stimulated response element.
Dansako H; Naganuma A; Nakamura T; Ikeda F; Nozaki A; Kato N
Virus Res; 2003 Nov; 97(1):17-30. PubMed ID: 14550584
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis C virus NS2 and NS3/4A proteins are potent inhibitors of host cell cytokine/chemokine gene expression.
Kaukinen P; Sillanpää M; Kotenko S; Lin R; Hiscott J; Melén K; Julkunen I
Virol J; 2006 Sep; 3():66. PubMed ID: 16945160
[TBL] [Abstract][Full Text] [Related]
8. Restoration of the activated Rig-I pathway in hepatitis C virus (HCV) replicon cells by HCV protease, polymerase, and NS5A inhibitors in vitro at clinically relevant concentrations.
Kalkeri G; Lin C; Gopilan J; Sloan K; Rijnbrand R; Kwong AD
Antimicrob Agents Chemother; 2013 Sep; 57(9):4417-26. PubMed ID: 23836176
[TBL] [Abstract][Full Text] [Related]
9. Cleavage of the IPS-1/Cardif/MAVS/VISA does not inhibit T cell-mediated elimination of hepatitis C virus non-structural 3/4A-expressing hepatocytes.
Ahlén G; Derk E; Weiland M; Jiao J; Rahbin N; Aleman S; Peterson DL; Pokrovskaja K; Grandér D; Frelin L; Sällberg M
Gut; 2009 Apr; 58(4):560-9. PubMed ID: 18689426
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C virus NS5B triggers an MDA5-mediated innate immune response by producing dsRNA without the replication of viral genomes.
Dansako H; Ikeda M; Ariumi Y; Togashi Y; Kato N
FEBS J; 2024 Mar; 291(6):1119-1130. PubMed ID: 37863517
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C virus NS4B protein targets STING and abrogates RIG-I-mediated type I interferon-dependent innate immunity.
Nitta S; Sakamoto N; Nakagawa M; Kakinuma S; Mishima K; Kusano-Kitazume A; Kiyohashi K; Murakawa M; Nishimura-Sakurai Y; Azuma S; Tasaka-Fujita M; Asahina Y; Yoneyama M; Fujita T; Watanabe M
Hepatology; 2013 Jan; 57(1):46-58. PubMed ID: 22911572
[TBL] [Abstract][Full Text] [Related]
12. Interference of HCV replication by cell penetrable human monoclonal scFv specific to NS5B polymerase.
Thueng-in K; Thanongsaksrikul J; Jittavisutthikul S; Seesuay W; Chulanetra M; Sakolvaree Y; Srimanote P; Chaicumpa W
MAbs; 2014; 6(5):1327-39. PubMed ID: 25517317
[TBL] [Abstract][Full Text] [Related]
13. Antiviral suppression vs restoration of RIG-I signaling by hepatitis C protease and polymerase inhibitors.
Liang Y; Ishida H; Lenz O; Lin TI; Nyanguile O; Simmen K; Pyles RB; Bourne N; Yi M; Li K; Lemon SM
Gastroenterology; 2008 Nov; 135(5):1710-1718.e2. PubMed ID: 18725224
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of amino acid mutations in hepatitis C virus core and NS5B regions among Venezuelan viral isolates and comparison with worldwide isolates.
Jaspe RC; Sulbarán YF; Sulbarán MZ; Loureiro CL; Rangel HR; Pujol FH
Virol J; 2012 Sep; 9():214. PubMed ID: 22995142
[TBL] [Abstract][Full Text] [Related]
15. Phosphorylation of hepatitis C virus RNA polymerases ser29 and ser42 by protein kinase C-related kinase 2 regulates viral RNA replication.
Han SH; Kim SJ; Kim EJ; Kim TE; Moon JS; Kim GW; Lee SH; Cho K; Yoo JS; Son WS; Rhee JK; Han SH; Oh JW
J Virol; 2014 Oct; 88(19):11240-52. PubMed ID: 25031343
[TBL] [Abstract][Full Text] [Related]
16. Impairment of interferon regulatory factor-3 activation by hepatitis C virus core protein basic amino acid region 1.
Inoue K; Tsukiyama-Kohara K; Matsuda C; Yoneyama M; Fujita T; Kuge S; Yoshiba M; Kohara M
Biochem Biophys Res Commun; 2012 Nov; 428(4):494-9. PubMed ID: 23122814
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of hepatitis C virus (HCV) core protein- induced cell growth by non-structural protein 4A (NS4A) is mediated by mitochondrial dysregulation.
Selimović D; Hassan M
Bosn J Basic Med Sci; 2008 Feb; 8(1):4-11. PubMed ID: 18318665
[TBL] [Abstract][Full Text] [Related]
18. Human Choline Kinase-α Promotes Hepatitis C Virus RNA Replication through Modulation of Membranous Viral Replication Complex Formation.
Wong MT; Chen SS
J Virol; 2016 Oct; 90(20):9075-95. PubMed ID: 27489281
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C virus core protein abrogates the DDX3 function that enhances IPS-1-mediated IFN-beta induction.
Oshiumi H; Ikeda M; Matsumoto M; Watanabe A; Takeuchi O; Akira S; Kato N; Shimotohno K; Seya T
PLoS One; 2010 Dec; 5(12):e14258. PubMed ID: 21170385
[TBL] [Abstract][Full Text] [Related]
20. Double-stranded RNA-induced interferon-beta and inflammatory cytokine production modulated by hepatitis C virus serine proteases derived from patients with hepatic diseases.
Dansako H; Ikeda M; Ariumi Y; Wakita T; Kato N
Arch Virol; 2009; 154(5):801-10. PubMed ID: 19353241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
